TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/7/20 20:25 | 2/6/20 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Piacquad David | CA | O | SVP,Busi | S | -2,130 | 229.93 | 0 | -9 | -19 | 40 | D | ||||||||||||||
12/13/19 20:31 | 12/13/19 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Piacquad David | CA | O | SVP,Busi | M.d | 467 | 162.60 | 0 | 3 | 6 | 49 | D | ||||||||||||||
11/20/19 20:09 | 11/20/19 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Piacquad David | CA | O | SVP,Busi | M.d | 899 | 156.35 | 0 | 6 | 13 | 48 | D | ||||||||||||||
12/3/18 20:13 | 11/30/18 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Piacquad David | CA | O | SVP,Busi | M.d | 355 | 54.69 | 0 | 7 | 19 | 41 | D | ||||||||||||||
5/15/18 19:55 | 5/11/18 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Piacquad David | CA | O | SVP,Busi | M.d | 821 | 54.71 | 0 | 15 | 56 | 42 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |